# Bank of America has identified 46 stocks that it believes could remain resilient and perform well irrespective of how the situation unfolds.

*business · news · 2026-04-07 · The Economic Times*

## Key points

- Bank of America has identified 46 stocks likely to remain resilient amid the Iran conflict.
- Twenty Indian pharmaceutical stocks are highlighted as likely to perform well regardless of war outcome.
- Titan Company and Kalyan Jewellers India are specifically named as resilient in the current geopolitical climate.
- Crude oil prices have surpassed $110 per barrel due to the prolonged Iran conflict.

**Companies:** Bank of America, Sun Pharma, Divis Laboratories, Torrent Pharmaceuticals, Lupin, Dr. Reddy’s Laboratories, Cipla, Zydus Lifesciences, Mankind Pharma, Aurobindo Pharma, Alkem Laboratories, Glenmark Pharmaceuticals, Laurus Labs, Biocon, Abbott India, GlaxoSmithKline Pharmaceuticals, IPCA Laboratories, Ajanta Pharma, Global Health (Medanta), Piramal Pharma, Syngene International, Titan Company, Kalyan Jewellers India
**Countries:** Iran

[Read the full story on The Economic Times](https://economictimes.indiatimes.com/markets/stocks/news/war-or-no-war-bofa-cites-nearly-50-stocks-that-could-perform-well-irrespective-of-geopolitical-outcome/slideshow/130075860.cms)

---

Canonical: https://newsio.io/n/2bcbbdf7-c188-480c-8254-2e82e96cbed5/bank-of-america-has-identified-46-stocks-that-it-believes-could-remain-resilient
Summarized by Newsio from The Economic Times. https://newsio.io/how-it-works